Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 14/20 | 0.44 |
| ▸ | IL2RA | P01589 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 1/20 | 0.36 |
| ▸ | IL2 | P60568 | 1/20 | 0.36 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.36 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.36 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24323874 | 0.90 | F2 (0.44) | F2IL2RAALBIL2TPSAB1 | |
| SCHEMBL24324301 | 0.88 | F2 (0.43) | F2IL2RAALBIL2TPSAB1 | |
| SCHEMBL24324275 | 0.87 | F2 (0.42) | F2IL2RAALBIL2TPSAB1 | |
| SCHEMBL24324307 | 0.84 | F2 (0.43) | F2IL2RAALBIL2TPSAB1 | |
| Hydrochloric Acid SCHEMBL9003150 | 0.84 | F2 (0.46) | F2IL2RAALBIL2TPSAB1 | |
| Hydrochloric Acid SCHEMBL9002657 | 0.82 | F2 (0.44) | F2IL2RAALBIL2TPSAB1 | |
| SCHEMBL24323889 | 0.79 | F2 (0.61) | F2TPSAB1TPSD1TPSG1ALDH1A1 | |
| SCHEMBL7390858 | 0.78 | F2 (0.43) | F2IL2RAALBIL2TPSAB1 | |
| SCHEMBL8947648 | 0.78 | F2 (0.72) | F2 | |
| SCHEMBL24323865 | 0.78 | F2 (0.40) | F2IL2RAALBIL2TPSAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | Psomagen Inc. (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | HTRA1, GIPR, HPN | F2 3514/4885IL2RA 3756/4885ALB 3874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.